Inspyr Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.67 |
Market Cap |
$598.5 K |
Shares Outstanding |
150 M |
Public Float |
9.17 M |
Address |
31200 Via Colinas Westlake Village California 91362 United States |
Employees | - |
Website | http://www.inspyrtx.com |
Updated | 07/08/2019 |
Inspyr Therapeutics, Inc. is a pharmaceutical company, which focuses on the development of prodrug cancer therapeutics for the treatment of solid tumors. The company's prodrug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. Its technology platform combines a powerful cytotoxin with a patented prodrug delivery system that targets the release of the drug within the tumor. |